BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10996202)

  • 21. Spectrum of complex chromosomal aberrations in a myelodysplastic syndrome and a brief review.
    Ganguly BB; Dolai TK; De R; Kadam NN
    J Cancer Res Ther; 2016; 12(3):1203-1206. PubMed ID: 28054536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AML-associated cytogenetic abnormalities (inv (16), del (16), t(8;21)) in patients with myelodysplastic syndromes.
    Estey E; Trujillo JM; Cork A; O'Brien S; Beran M; Kantarjian H; Keating M; Freireich EJ; Stass S
    Hematol Pathol; 1992; 6(1):43-8. PubMed ID: 1601822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes.
    Solé F; Luño E; Sanzo C; Espinet B; Sanz GF; Cervera J; Calasanz MJ; Cigudosa JC; Millà F; Ribera JM; Bureo E; Marquez ML; Arranz E; Florensa L
    Haematologica; 2005 Sep; 90(9):1168-78. PubMed ID: 16154839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New complex t(2;11;17)(p21;q23;q11), a variant form of t(2;11), associated with del(5)(q23q32) in myelodysplastic syndrome-derived acute myeloblastic leukemia.
    Yamamoto K; Nagata K; Morita Y; Inagaki K; Hamaguchi H
    Cancer Genet Cytogenet; 2002 Sep; 137(2):119-23. PubMed ID: 12393282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of cytogenetic, molecular cytogenetic, and clinical findings in 59 patients with ANLL or MDS and abnormalities of the short arm of chromosome 12.
    Streubel B; Sauerland C; Heil G; Freund M; Bartels H; Lengfelder E; Wandt H; Ludwig WD; Nowotny H; Baldus M; Grothaus-Pinke B; Büchner T; Fonatsch C
    Br J Haematol; 1998 Mar; 100(3):521-33. PubMed ID: 9504635
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary chromosomal abnormalities in acute leukemias.
    Johansson B; Mertens F; Mitelman F
    Leukemia; 1994 Jun; 8(6):953-62. PubMed ID: 8207990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute leukaemia and myelodysplastic syndromes with chromosomal rearrangement involving 11q23 locus, but not
    Zuo W; Wang SA; DiNardo C; Yabe M; Li S; Medeiros LJ; Tang G
    J Clin Pathol; 2017 Mar; 70(3):244-249. PubMed ID: 27496968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse and cytogenetic evolution in myeloid neoplasms.
    Ertz-Archambault N; Kelemen K
    Panminerva Med; 2017 Dec; 59(4):308-319. PubMed ID: 29144072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytogenetically unrelated clones in therapy-related myelodysplasia and acute myeloid leukemia: experience from the Copenhagen series updated to 180 consecutive cases.
    Pedersen-Bjergaard J; Timshel S; Andersen MK; Andersen AS; Philip P
    Genes Chromosomes Cancer; 1998 Dec; 23(4):337-49. PubMed ID: 9824207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Consecutive chromosomal studies in patients with myelodysplastic syndrome (MDS). Czechoslovak MDS Cooperative Group.
    Michalova K; Musilova J; Zemanova Z
    Ann Genet; 1991; 34(3-4):212-8. PubMed ID: 1809229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myelodysplastic Syndrome with t(1;14),t(1;17),t(1;19) Transforms to AML-M5: A Case Report and Literature Review.
    Zhang H; Li G; Chang J; Wang H
    Ann Clin Lab Sci; 2020 May; 50(3):401-403. PubMed ID: 32581034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 11q23 balanced chromosome aberrations in treatment-related myelodysplastic syndromes and acute leukemia: report from an international workshop.
    Bloomfield CD; Archer KJ; Mrózek K; Lillington DM; Kaneko Y; Head DR; Dal Cin P; Raimondi SC
    Genes Chromosomes Cancer; 2002 Apr; 33(4):362-78. PubMed ID: 11921271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
    Grimwade D; Hills RK; Moorman AV; Walker H; Chatters S; Goldstone AH; Wheatley K; Harrison CJ; Burnett AK;
    Blood; 2010 Jul; 116(3):354-65. PubMed ID: 20385793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
    Slovak ML; O'Donnell M; Smith DD; Gaal K
    Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique cytogenetic features of primary myelodysplastic syndromes in Chinese patients.
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Leuk Res; 2009 Sep; 33(9):1194-8. PubMed ID: 19128829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on karyotypic abnormalities and its prognostic significance in Chinese patients with primary myelodysplastic syndromes].
    Li L; Liu XP; Nie L; Yu MH; Zhang Y; Qin TJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):217-22. PubMed ID: 19731819
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unbalanced translocation der(11)t(11;12)(q23;q13): a new recurrent cytogenetic aberration in myelodysplastic syndrome with a complex karyotype.
    Yamamoto K; Hato A; Minagawa K; Yakushijin K; Urahama N; Gomyo H; Sada A; Okamura A; Ito M; Matsui T
    Cancer Genet Cytogenet; 2004 Nov; 155(1):67-73. PubMed ID: 15527905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patients with del(5q) MDS who fail to achieve sustained erythroid or cytogenetic remission after treatment with lenalidomide have an increased risk for clonal evolution and AML progression.
    Göhring G; Giagounidis A; Büsche G; Kreipe HH; Zimmermann M; Hellström-Lindberg E; Aul C; Schlegelberger B
    Ann Hematol; 2010 Apr; 89(4):365-74. PubMed ID: 19855965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.
    Walker A; Mrózek K; Kohlschmidt J; Rao KW; Pettenati MJ; Sterling LJ; Marcucci G; Carroll AJ; Bloomfield CD;
    Genes Chromosomes Cancer; 2013 Apr; 52(4):385-401. PubMed ID: 23225546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
    Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
    Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.